Opaganib 2 mg | 98.86%
TargetMol
Opaganib (ABC294640) is an orally active and specific sphingosine kinase-2 (SphK2) inhibitor (IC50: 60 μM).
More Information Supplier PageOpaganib
Search Results
FIIN-2 10 mg | 99.34%
TargetMol
FIIN-2, an irreversible, pan-FGFR inhibitor, inhibits FGFR1/2/3/4 with IC50 of 3.09 nM, 4.3 nM, 27 nM and 45.3 nM, respectively.
More Information Supplier PageFIIN-2 50 mg | 99.34%
TargetMol
FIIN-2, an irreversible, pan-FGFR inhibitor, inhibits FGFR1/2/3/4 with IC50 of 3.09 nM, 4.3 nM, 27 nM and 45.3 nM, respectively.
More Information Supplier PageZM241385 5 mg | 95.28%
TargetMol
ZM-241385 is a high-affinity antagonist ligand selective for the adenosine A2A receptor.
More Information Supplier PageZM241385
SB 239063 50 mg | 99.81%
TargetMol
SB239063 is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms.
More Information Supplier PageSB 239063
SB 239063 10 mg | 99.81%
TargetMol
SB239063 is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms.
More Information Supplier PageSB 239063
SB 239063 2 mg | 99.81%
TargetMol
SB239063 is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms.
More Information Supplier PageSB 239063
Prilocaine 200 mg | Purity Not Available
TargetMol
Prilocaine is a local anesthetic of the amino amide type, which acts on the sodium channel on the neuronal membrane and limits the spread of seizures.
More Information Supplier PagePrilocaine
Prilocaine 25 mg | Purity Not Available
TargetMol
Prilocaine is a local anesthetic of the amino amide type, which acts on the sodium channel on the neuronal membrane and limits the spread of seizures.
More Information Supplier PagePrilocaine
Liraglutide 10 mg | 99.04%
TargetMol
Liraglutide
